- Home
- TECH vs BEP Comparison
TECH vs BEP Comparison
Compare TECH & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- BEP
- Stock Information
- Founded
- TECH 1976
- BEP 1999
- Country
- TECH United States
- BEP Canada
- Employees
- TECH N/A
- BEP N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- BEP Electric Utilities: Central
- Sector
- TECH Health Care
- BEP Utilities
- Exchange
- TECH Nasdaq
- BEP Nasdaq
- Market Cap
- TECH 8.9B
- BEP 8.7B
- IPO Year
- TECH 1989
- BEP N/A
- Fundamental
- Price
- TECH $64.75
- BEP $28.43
- Analyst Decision
- TECH Strong Buy
- BEP Buy
- Analyst Count
- TECH 14
- BEP 10
- Target Price
- TECH $71.23
- BEP $33.90
- AVG Volume (30 Days)
- TECH 2.1M
- BEP 1.2M
- Earning Date
- TECH 11-05-2025
- BEP 11-05-2025
- Dividend Yield
- TECH 0.50%
- BEP 5.28%
- EPS Growth
- TECH N/A
- BEP N/A
- EPS
- TECH 0.49
- BEP N/A
- Revenue
- TECH $1,216,732,000.00
- BEP $6,300,000,000.00
- Revenue This Year
- TECH $3.64
- BEP $17.43
- Revenue Next Year
- TECH $7.59
- BEP $8.13
- P/E Ratio
- TECH $132.78
- BEP N/A
- Revenue Growth
- TECH 3.85
- BEP 9.24
- 52 Week Low
- TECH $46.01
- BEP $19.29
- 52 Week High
- TECH $79.28
- BEP $32.72
- Technical
- Relative Strength Index (RSI)
- TECH 62.28
- BEP 44.74
- Support Level
- TECH $57.02
- BEP $28.04
- Resistance Level
- TECH $66.06
- BEP $29.21
- Average True Range (ATR)
- TECH 2.06
- BEP 0.54
- MACD
- TECH 0.56
- BEP -0.27
- Stochastic Oscillator
- TECH 86.04
- BEP 11.05
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.